MONCTON, NEW BRUNSWICK--(Marketwired - Aug. 30, 2017) - Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the "Company" or "Organigram") is pleased to announce that it will be presenting at MJAC2017 - InvestorsHub International Cannabis Conference, on Friday, September 1, 2017 and Saturday, September 2, 2017. The event is being held at the JW Marriott Los Angeles L.A. LIVE, 900 West Olympic Boulevard in Los Angeles, California.

Greg Engel, Chief Executive Officer of Organigram will present to conference attendees Friday afternoon and Ray Gracewood, Chief Commercial Officer of Organigram will present to investors Saturday morning.

Organigram management will also conduct a series of one-on-one meetings with institutional investors.

Registered attendees interested in scheduling a meeting with management should contact conference coordinators.

Further, the Company announces that it has granted 50,000 stock options to an officer of the Company pursuant to contractual obligations. The options were issued on August 25, 2017 with an exercise price of $2.27 per share.

For more information, visit

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

Organigram has been ranked in the top ten Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

Contact Information:

Organigram Holdings Inc.
Greg Engel
Chief Executive Officer

Organigram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986